EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predictive Modeling of Treatment-Related Thyroid Dysfunction and Prognostic Implication in Advanced Nasopharyngeal Carcinoma With PD-1 Inhibitors

Yubin Hu, Xinyi Hong, Yi Li, Honghong Zhang, Mohammad Abidullah Warsi, Ronghui Chen, Chaoying Lin, Peidong Ou, Cuibo Lin, Sufang Qiu iD

The Oncologist · 2026

DOI: 10.1093/oncolo/oyag066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, 2026. Verfasst von Yubin Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Sh…. Hauptthemen laut MEDLINE: Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitors, Nasopharyngeal Neoplasms, Thyroid Diseases. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Provincial Clinical Research Center for Cancer Radiotherapy and Immunotherapy, National Clinical Key Specialty Construction Program (2021), Fujian Clinical Research Center for Radiation and Therapy of Digestive, Respiratory and Genitourinary Malignancies.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Treatment-related thyroid dysfunction (trTD) frequently occurs in advanced nasopharyngeal carcinoma (NPC) patients treated with PD-1 inhibitors. Its clinical features, incidence, and prognostic value remain unclear. This study aimed to characterize trTD and assess its impact on survival.

Methods

We retrospectively analyzed 168 advanced NPC patients who received PD-1 inhibitor therapy between 2019 and 2022. Cox proportional hazards models and Kaplan-Meier analysis were used to assess the prognostic significance of trTD. Clinical factors associated with trTD were identified through logistic regression. A predictive nomogram was constructed and evaluated using receiver operating characteristic (ROC) and calibration curves. Spearman correlation analysis was performed to assess the dynamic relationship between thyroid function indicators and treatment duration.

Results

TrTD developed in 49.4% of patients, mostly mild, including hyperthyroidism, hypothyroidism, and biphasic dysfunction. TrTD was independently associated with improved progression free survival (PFS). Female, elevated ALB, ALT, and TBIL were independent risk factors for trTD. The nomogram constructed by combining these factors and thyroid indicators had good prediction accuracy (AUC = 0.781). Dynamic analysis revealed that TSH levels significantly increased after the fourth treatment cycle, preceding changes in FT3 and FT4, suggesting TSH as a potential early biomarker for trTD onset.

Conclusion

This study identifies trTD as a common event associated with improved survival in advanced NPC patients treated with PD-1 inhibitors. A predictive nomogram and early TSH elevation provide valuable tools for risk stratification and personalized immunotherapy monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nasopharyngeal CarcinomaImmune Checkpoint InhibitorsNasopharyngeal NeoplasmsThyroid DiseasesHumansFemalePrognosisMaleRetrospective StudiesMiddle AgedProgrammed Cell Death 1 ReceptorAdultNomogramsAged

Stichwörter der Autor:innen

immune checkpoint inhibitorsnasopharyngeal carcinomathyroid dysfunction

Substanzen

Immune Checkpoint InhibitorsProgrammed Cell Death 1 ReceptorPDCD1 protein, human

Autor:innen und Institutionen

  • Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fujian 350014, People's Republic of China.
  • Department of Radiation Oncology, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361005, People's Republic of China.
  • Fujian Key Laboratory of Translational Cancer Medicine, Fujian 350014, People's Republic of China.

ORCID-Profile: Sufang Qiu

Förderung

  • Fujian Provincial Clinical Research Center for Cancer Radiotherapy and Immunotherapy
  • National Clinical Key Specialty Construction Program (2021)
  • Fujian Clinical Research Center for Radiation and Therapy of Digestive, Respiratory and Genitourinary Malignancies
  • National Natural Science Foundation of China
  • Major Scientific Research Program for Young and Middle-aged Health Professionals of Fujian Province
  • Joint Funds for the Innovation of Science and Technology
  • Natural Science Foundation of Fujian Province
  • High-level Talent Training Program of Fujian Cancer Hospital

Zitieren

APA

Hu, Y., Hong, X., Li, Y., Zhang, H., Warsi, M. A., Chen, R., Lin, C., Ou, P., Lin, C., & Qiu, S. (2026). Predictive Modeling of Treatment-Related Thyroid Dysfunction and Prognostic Implication in Advanced Nasopharyngeal Carcinoma With PD-1 Inhibitors. The Oncologist. https://doi.org/10.1093/oncolo/oyag066

Vancouver

Hu Y, Hong X, Li Y, Zhang H, Warsi MA, Chen R, et al. Predictive Modeling of Treatment-Related Thyroid Dysfunction and Prognostic Implication in Advanced Nasopharyngeal Carcinoma With PD-1 Inhibitors. The Oncologist. 2026. doi:10.1093/oncolo/oyag066

BibTeX
@article{Hu2026,
  author = {Hu, Yubin and Hong, Xinyi and Li, Yi and Zhang, Honghong and Warsi, Mohammad Abidullah and Chen, Ronghui and Lin, Chaoying and Ou, Peidong and Lin, Cuibo and Qiu, Sufang},
  title = {Predictive Modeling of Treatment-Related Thyroid Dysfunction and Prognostic Implication in Advanced Nasopharyngeal Carcinoma With PD-1 Inhibitors},
  journal = {The Oncologist},
  year = {2026},
  doi = {10.1093/oncolo/oyag066}
}
Kostenlos starten →